Briana Huisken, PA
Physician Assistant · Grand Rapids, MINPI 1366180044
Payments from drug & device makers
Across 132 payments — averaging $25.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Xeris Pharmaceuticals, Inc.$1K
- Boehringer Ingelheim$825
- Novo Nordisk$569
- Tandem Diabetes Care, Inc.$275
- Dexcom, Inc.$254
- Sequel Med Tech, LLC$181
- plus $227 from 5 others
What the payments were for
- Speaking & faculty fees$35010%
- Food & beverage$3,06090%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 40 | $1,080 |
| Boehringer Ingelheim | 16 | $825 |
| Novo Nordisk | 58 | $569 |
| Tandem Diabetes Care, Inc. | 4 | $275 |
| Dexcom, Inc. | 4 | $254 |
| Sequel Med Tech, LLC | 3 | $181 |
| Medtronic | 1 | $122 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Lilly USA, LLC | 2 | $29 |
| Insulet Corporation | 1 | $24 |
| Ascendis Pharma Endocrinology Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$593
- GVOKE HYPOPEN$350
- TWIIST$146
- DEXCOM G7 GSS (161)$128
- Ozempic$125
- MINIMED 780G$122
How this compares
$3,410 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 126 | $152,566 |
| JardianceEmpagliflozin | 61 | $72,321 |
| TrulicityDulaglutide | 45 | $64,347 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $41,101 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 42 | $39,373 |
| Humalog Kwikpen U-200Insulin Lispro | 14 | $34,302 |
| OzempicSemaglutide | 26 | $31,315 |
| Humalog Kwikpen U-100Insulin Lispro | 69 | $22,333 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 133 | $19,234 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $16,507 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $12,797 |
| Novolog FlexpenInsulin Aspart | 31 | $11,729 |
| HumalogInsulin Lispro | 29 | $11,342 |
| Gvoke Hypopen 2-PackGlucagon | 18 | $10,573 |
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 56 | $8,181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Baqsimi | $29 | $235,649216 claims |
| Boehringer IngelheimJardiance | $825 | $72,32161 claims |
| Novo NordiskOzempic, Novolog | $569 | $36,12741 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Grand Rapids
- Erin van DykeGrand Rapids$346K
- Melissa JosephGrand Rapids$82K
- Matthew SchultzGrand Rapids$49K
- Shannon ToddGrand Rapids$32K
- Patrick HandlinGrand Rapids$28K
- John MulderGrand Rapids$27K
- Ginger BiesbrockGrand Rapids$25K
- Matthew ZoetemanGrand Rapids$23K
- Aaron ZarnoskyGrand Rapids$22K
- Sarang PatelRoyal Oak$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.